Guardant Health (NASDAQ: GH) notice: proposed sale of 1,000 shares
Rhea-AI Filing Summary
Guardant Health lists a proposed sale of 1,000 shares of Common stock. The filing states the sale relates to a restricted stock lapse dated 10/17/2025 and is identified as equity compensation. The excerpt also shows past sales by Manuel Hidalgo Medina: 1,300 shares on 03/06/2026 for $118,997.00 and 1,250 shares on 05/20/2026 for $133,864.00.
Positive
- None.
Negative
- None.
Insights
Routine disclosure of a proposed resale tied to vested compensation and recent small insider sales.
The filing records a proposed sale of 1,000 shares following a restricted stock lapse dated 10/17/2025, labeled as equity compensation. This is a standard Form 144 notice that permits a broker or holder to sell shares under Rule 144 after vesting or lapse events.
Examples shown include two recent dispositions by Manuel Hidalgo Medina: 1,300 shares on 03/06/2026 for $118,997.00 and 1,250 shares on 05/20/2026 for $133,864.00. Cash‑flow treatment and broader position details are timing- and holder-specific in the excerpt.